Search results
Results From The WOW.Com Content Network
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) [2] is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations [3] where it contributes industry expertise to global ...
In November 2024, IFPMA announced that Schinecker would replace Albert Bourla as President. [22] Personal life. Schinecker is married and has three children.
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), president (2014-2016) [20] Personal life. Oschmann and his wife have two children. [3]
The IFPMA Clinical Trials Portal is a major pharmaceutical industry initiative designed to increase the transparency of clinical trials by providing a convenient "one-stop-shop" for published clinical trial information.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), [7] the Biotechnology Innovation Organization (BIO), [8] the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), [9] and the Pharmaceutical Research and Manufacturers of America (PhRMA). [10]
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) – IFPMA represents the research-based pharmaceutical industry, including the biotechnology and vaccine sectors. NGO forum for Health – The NGO Forum for Health is a Geneva-based consortium of health organisations, committed to promoting human rights and quality ...
Member of the council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), [14] Member of the Board of Management of the Pharmaceutical Research and Manufacturers of America (PhRMA). [15] Vice-president of the European Federation of Pharmaceutical Industries and Associations (EFPIA); [16]
As chairman of the Pharmaceutical Research and Manufacturers Association (PhRMA) [7] (from 2002 to 2003) and president of the International Federation of Pharmaceutical Associations (IFPMA) (from 2006 to 2009), Hassan led initiatives on voluntary guidelines for promotional practices and for fuller disclosure of clinical trials. In 2003, Hassan ...